ENZY.ST
Enzymatica AB [ENZY.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ENZY.ST Stock Summary
Top 10 Correlated ETFs
ENZY.ST
Top 10 Correlated Stocks
ENZY.ST
In the News
ENZY.ST Financial details
Company Rating
-
Market Cap
702.06M
Income
-49.73M
Revenue
50.9M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
18
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
-10.24
Forward P/E
-
PEG
3.28
P/S
12.11
P/B
6.43
P/C
-
P/FCF
-9.56
Quick Ratio
0.56
Current Ratio
2.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.3
EPS next Y
-
EPS next Q
-
EPS this Y
-31.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.68%
Revenue last 5Y
-3.65%
Revenue Q/Q
19.34%
EPS Q/Q
52.31%
-
-
-
-
SMA20
-26.22%
SMA50
100%
SMA100
86.52%
Inst Own
-
Inst Trans
-
ROA
-41%
ROE
-54%
ROC
-0.48%
Gross Margin
63%
Oper. Margin
-108%
Profit Margin
-112%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.1-4.425
52W High
-27%
52W Low
+46%
RSI
37.39
Rel Volume
1.02
Avg Volume
71.16K
Volume
72.93K
Perf Week
-14.87%
Perf Month
-30.14%
Perf Quarter
68.79%
Perf Half Y
64.97%
-
-
-
-
Beta
-0.071
-
-
Volatility
0.18%, 0.6%
Prev Close
-6.41%
Price
2.92
Change
-8.46%
Company Profile
- Volume Average 71.16K
- Market Capitalization 702.06M
- Employee 18
- CEO Mr. Claus Egstrand
- Headquarters Lund,SE
- IPO Date 2011-06-14
-
Website
https://www.enzymatica.se 
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme mouth spray, which prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells mouth spray under the ViruProtect brand in Denmark; STADAProtect brand in Germany; Psysiomer Stop Virus brand in France; and Zerinol Virus Defense brand in Italy. Enzymatica AB was incorporated in 2007 and is headquartered in Lund, Sweden.
